United States: Accord BioPharma, Inc. Announces FDA Approval Of HERCESSI (Trastuzumab-strf) - Goodwin Procter LLP

United States: Accord BioPharma, Inc. Announces FDA Approval Of HERCESSI (Trastuzumab-strf) - Goodwin Procter LLP

Mondaq

Published

On April 29, 2024, Accord BioPharma, Inc. announced that the U.S. Food and Drug Administration (FDA) approved HERCESSI (trastuzumab-strf).

Full Article